Efficacy, Safety and Pharmacokinetic of Virchow IVIG in PID Patients

计划入组 44 人 · 首次发布于 2025 年 6 月 12 日

A-dmDT390-bisFv(UCHT1) Fusion Protein in Combination With Ionizing Radiation for Treatment of Stage IV Melanoma

计划入组 2 人 · 首次发布于 2013 年 6 月 27 日

The Effects of a Glutathione Precursor (FT061452),on Serum and Intracellular Glutathione Levels

计划入组 24 人 · 首次发布于 2010 年 12 月 1 日

Ovarian Cancer (ErVimmune)

Ovarian Cancer (Engineered TCR) (ErVimmune)

Triple-Negative Breast Cancer (Engineered TCR) (ErVimmune)

Persimmune, Inc.

United States

NovImmune SA

Switzerland

ENIMMUNE CORPORATION

Taiwan

ErVimmune Raises €17 Million to Advance Off-the-Shelf Cancer Vaccine Targeting Human Endogenous Retroviruses

Evommune Advances Two Novel Inflammatory Disease Programs Following $172.5M IPO

Evommune's EVO756 Enters Phase 2 Trial for Chronic Inducible Urticaria